| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $5K | +100.0% |
| R&D Expense | $1.3M | — |
| SG&A Expense | $332K | +510.6% |
| Operating Income | -$2.9M | -849.1% |
| Pre-tax Income | -$2.9M | -878.3% |
| Net Income | -$2.9M | -872.9% |
| EPS (Basic) | -$0.32 | -966.7% |
| EPS (Diluted) | -$0.32 | -966.7% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Current Assets | $58K | +15.3% |
| Total Assets | $70.2M | +3786.2% |
| Current Liabilities | $1.1M | +3924.5% |
| Total Liabilities | $10.4M | — |
| Stockholders' Equity | $59.9M | +3261.0% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | -396.1% |
| Investing Cash Flow | $148K | — |
| Financing Cash Flow | $1.1M | +253.8% |